All News

PSA velocity is a poor predictor of prostate cancer and may lead to many unnecessary biopsies, according to a recent study.

The RANK Ligand inhibitor denosumab (Xgeva) significantly delays skeletal-related events (SREs) in men with prostate cancer and bone metastases, French researchers recently reported.

A genetic pattern may predict how aggressive prostate cancer is before treatment and whether the disease will recur in men who have already been treated, according to research from Queen Mary, University of London.

The AUA has released its first clinical guideline on the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).

A new health education campaign is harnessing the power of sports and celebrities to bring prostate cancer to the forefront as a critical men's health issue and to challenge men to take charge of their health.

The FDA has cleared a test to help manage potential organ rejection in kidney transplant patients.

External beam radiation therapy (EBRT) remains the mainstay for treating bone metastases, according to a new American Society for Radiation Oncology guideline for the use of radiation therapy in treating bone metastases.

In a collaborative project involving scientists from three continents, researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer.

A new blood test can detect the abnormal pattern of chemical alteration of DNA associated with bladder cancer, suggesting it may be possible to assess susceptibility to the disease, say researchers from Brown University, Providence, RI.

Nerve-sparing radical prostatectomy is likely to help preserve erectile function regardless of the route of operation; however, nerve sparing appears to have no impact on the prevalence of postoperative incontinence.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II, III, and IV overactive bladder trials that are currently recruiting participants as well as phase II BPH trials. This list is current as of Feb. 16, 2011.

Urology drugs and devices that are in the pipeline from Exelixis, Inc., ADVENTRX Pharmaceuticals, Viking Systems, Inc., Epigenomics AG, and Predictive Biosciences.

The Reid Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010 will likely affect your 2010 taxes.

For practicing urologists, triaging genitourinary care for children can be more difficult than it is for adults, but it doesn't have to be. Clear and concise GU diagnosis and treatment should help maximize overall care.

It appears that large administrative datasets correlate very poorly with validated questionnaire data, the gold standard for outcome assessment.

Combined male-/female-factor infertility in couples results in the highest costs for treatment compared to male-factor or female-factor infertility only.

Urologists say they average around 10 to 15 minutes with each patient.

In vitro evidence suggests that increasing the energy level more slowly could not only improve fragmentation but also minimize renal injury. But a controlled, randomized trial didn't corroborate that evidence.

Many commonly prescribed antibiotics may inhibit colonization of Oxalobacter formigenes, a bacterium that lowers the risk of calcium oxalate calculi.

If we are to accurately assess the potential advantages or disadvantages of any new technique or treatment, we must apply rigorous scientific standards and use validated instruments with comparisons to the contemporary gold standard.

Urologists respond to the FDA's ruling on dutasteride and finasteride.

With huge Medicare reimbursement cuts for physicians now off the table for this year, the Medicare Payment Advisory Commission (MedPAC) has proposed a 1% increase for 2012 as a way of encouraging physicians to continue to treat Medicare patients.

Results of pathologic analysis of buccal mucosa used in first- and second-stage adult urethroplasty procedures shows it is a robust tissue for grafting.

A "urethral rest" period appears to be beneficial for optimizing disease delineation in patients referred for anterior urethroplasty.

The issues surrounding running a urology practice are much more complicated today, and having business/administrative knowledge as well as a medical degree may be one option that can help us through the labyrinth of medical practice.

When weighing the value and efficacy of two ablation technologies used in the treatment of BPH-holmium laser ablation and photoselective vaporization-surgeons should factor the size of the prostate into their deliberations.

The newest urology products and services from Endo Pharmaceuticals, UroMed, Hunter House Publishers, and Women Against Prostate Cancer.

Adding the no-calorie sweetener sucralose (Splenda) to a potassium citrate solution might improve patient compliance with citrate supplementation.

You cannot charge Medicare for the catheter when billing for a catheter insertion.

Novel backloading ureteroscopic biopsy forceps allow physicians to obtain larger specimens of upper tract lesions.